PUBBLICAZIONI CLINICA METABOLICA
Pubblicazioni 2016
Le seguenti pubblicazioni sono state pubblicate nel corso dell’anno 2016
The PNPLA3 Genetic Variant rs738409 Influences the Progression to Cirrhosis in HIV/Hepatitis C Virus Coinfected Patients.
Núñez-Torres R, Macías J, Mancebo M, Frías M, Dolci G, Téllez F, Merino D, Merchante N, Gómez-Mateos J, Guaraldi G, Rivero-Juárez A, Pineda JA, Real LM; HEPAVIR-esteatosis Study Group.
PLoS One. 2016 Dec 14;11(12):e0168265. doi: 10.1371/journal.pone.0168265. eCollection 2016.
Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV.
Lonardo A, Ballestri S, Guaraldi G, Nascimbeni F, Romagnoli D, Zona S, Targher G.
World J Gastroenterol. 2016 Nov 28;22(44):9674-9693. Review.
Emphysema Distribution and Diffusion Capacity Predict Emphysema Progression in Human Immunodeficiency Virus Infection.
Leung JM, Malagoli A, Santoro A, Besutti G, Ligabue G, Scaglioni R, Dai D, Hague C, Leipsic J, Sin DD, Man SP, Guaraldi G.
PLoS One. 2016 Nov 30;11(11):e0167247. doi: 10.1371/journal.pone.0167247. eCollection 2016.
[Treating HIV disease: back to the patient?]
Girardi E, d'Arminio Monforte A, Camoni L, Pezzotti P, Guaraldi G, Ammassari A, Antinori A, Bonora S, Mussini C, Cingolani A, Corbelli GM, Adami S, Degli Esposti L, Andretta M.
Recenti Prog Med. 2016 Oct;107(10):525-550. doi: 10.1701/2454.25704. Italian.
Nonalcoholic steatohepatitis heralding olmesartan-induced sprue-like enteropathy.
Non-Alcoholic Fatty Liver Disease Study Group, Dolci M, Nascimbeni F, Romagnoli D, Reggiani Bonetti L, Guaraldi G, Mascia MT, Lonardo A.
Dig Liver Dis. 2016 Nov;48(11):1399-1401. doi: 10.1016/j.dld.2016.07.004. Epub 2016 Jul 15. No abstract available.
The transition from co-morbidities to geriatric syndromes in HIV.
Guaraldi G.
Germs. 2016 Sep 1;6(3):79-81. doi: 10.11599/germs.2016.1092. eCollection 2016 Sep. No abstract available.
Prediction of hard cardiovascular events in HIV patients.
Raggi P, De Francesco D, Manicardi M, Zona S, Bellasi A, Stentarelli C, Carli F, Beghetto B, Mussini C, Malagoli A, Guaraldi G.
J Antimicrob Chemother. 2016 Dec;71(12):3515-3518. Epub 2016 Sep 2.
Clinical Research Nurse involvement to foster a community based transcultural research in RODAM European study.
Caselgrandi A, Guaraldi G, Cottafavi K, Artioli G, Ferri P.
Acta Biomed. 2016 May 26;87 Suppl 2:80-7.
Kidney Transplantation in HIV-Infected Recipients: Therapeutic Strategy and Outcomes in Monocentric Experience.
Baisi A, Nava F, Baisi B, Rubbiani E, Guaraldi G, Di Benedetto F, Giovannoni M, Solazzo A, Bonucchi D, Cappelli G.
Transplant Proc. 2016 Mar;48(2):333-6. doi: 10.1016/j.transproceed.2015.12.038.
Treatment of severe recurrent hepatitis C after liver transplantation in HIV infected patients using sofosbuvir-based therapy.
Campos-Varela I, Moreno A, Morbey A, Guaraldi G, Hasson H, Bhamidimarri KR, Castells L, Grewal P, Baños I, Bellot P, Brainard DM, McHutchison JG, Terrault NA.
Aliment Pharmacol Ther. 2016 Jun;43(12):1319-29. doi: 10.1111/apt.13629. Epub 2016 Apr 21.
Atazanavir/ritonavir monotherapy: 96 week efficacy, safety and bone mineral density from the MODAt randomized trial.
Galli L, Spagnuolo V, Bigoloni A, D'Arminio Monforte A, Montella F, Antinori A, Di Biagio A, Rusconi S, Guaraldi G, Di Giambenedetto S, Borderi M, Gibellini D, Caramatti G, Lazzarin A, Castagna A; MODAt Study Group.
J Antimicrob Chemother. 2016 Jun;71(6):1637-42. doi: 10.1093/jac/dkw031. Epub 2016 Mar 5.
More than osteoporosis: age-specific issues in bone health.
Erlandson KM, Guaraldi G, Falutz J.
Curr Opin HIV AIDS. 2016 May;11(3):343-50. doi: 10.1097/COH.0000000000000258. Review.
Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis.
Ballestri S, Zona S, Targher G, Romagnoli D, Baldelli E, Nascimbeni F, Roverato A, Guaraldi G, Lonardo A.
J Gastroenterol Hepatol. 2016 May;31(5):936-44. doi: 10.1111/jgh.13264. Review.
An Update on Heart Transplantation in Human Immunodeficiency Virus-Infected Patients.
Agüero F, Castel MA, Cocchi S, Moreno A, Mestres CA, Cervera C, Pérez-Villa F, Tuset M, Cartañà R, Manzardo C, Guaraldi G, Gatell JM, Miró JM.
Am J Transplant. 2016 Jan;16(1):21-8. doi: 10.1111/ajt.13496. Epub 2015 Nov 2. Review.
Serum total estradiol, but not testosterone is associated with reduced bone mineral density (BMD) in HIV-infected men: a cross-sectional, observational study.
Santi D, Madeo B, Carli F, Zona S, Brigante G, Vescini F, Guaraldi G, Rochira V.
Osteoporos Int. 2016 Mar;27(3):1103-1114. doi: 10.1007/s00198-015-3383-8. Epub 2015 Oct 28.
Raltegravir Plus Nevirapine as Maintenance Antiretroviral Therapy in HIV-Positive Patients: Safety, Efficacy and Pharmacokinetics.
Calcagno A, Montrucchio C, Capetti A, Guaraldi G, Cenderello G, Calza L, Lanzafame M, Marinaro L, Tettoni MC, Trentini L, D'Avolio A, Di Perri G, Bonora S.
Curr HIV Res. 2016;14(1):54-60.
Independent association of subclinical coronary artery disease and emphysema in HIV-infected patients.
Besutti G, Raggi P, Zona S, Scaglioni R, Santoro A, Orlando G, Ligabue G, Leipsic J, Sin DD, Man SF, Guaraldi G.
HIV Med. 2016 Mar;17(3):178-87. doi: 10.1111/hiv.12289. Epub 2015 Aug 13.
TUTTE LE NOSTRE PUBBLICAZIONI
Siamo lieti
di accoglierti
Chiedici informazioni
o prenota la tua prima visita
presso la Clinica Metabolica
di Modena